The new center, supported by a $5 million grant from the Agency for Healthcare Research and Quality and the Patient-Centered Outcomes Research Institute will focus on training scientists and supporting research to minimize gaps between the generation of clinical evidence, implementation of proven interventions and development of informed public health policy.

The STAR Clinical Research Network, based at Vanderbilt University Medical Center (VUMC), has added two new partners — Essentia Health, a Minnesota-based rural health care system, and Stanford University School of Medicine, one of the country’s leading academic medical centers.

Researchers at Vanderbilt University Medical Center have received a four-year, $28 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases to study the relationship between COVID-19 and diabetes.

Vanderbilt research finds that female health care workers were more likely to leave or intend to leave the profession compared to male health care workers during the COVID-19 pandemic.

Vanderbilt's STAR Clinical Research Network has been approved for an additional $8.9 million in funding from the Patient-Centered Outcomes Research Institute (PCORI) to support its efforts to improve health care throughout the Southeast and across the United States.

According to an innovative large-scale clinical trial reported last week in the New England Journal of Medicine, a single daily baby aspirin (81 mg) or a single daily adult aspirin (325 mg) are equally safe and effective for prevention of adverse cardiovascular events for patients with established atherosclerotic cardiovascular disease.

Health care workers, who have been disproportionately affected by the COVID-19 pandemic, will be the first tier of Vanderbilt University Medical Center employees to receive vaccine to prevent SARS-CoV-2 infection.